OCA-CC demonstrated enhanced cytosolic delivery in three tumor cells (A549, MCF-7 and PANC-1) and displayed remarkable antitumor efficacy in vitro and in vivo via silencing survivin expression [132]. This evidence concerns the gene BIRC5 and neoplasm.